316 related articles for article (PubMed ID: 7865691)
41. Fibrinolysis in disseminated intravascular coagulation.
Hack CE
Semin Thromb Hemost; 2001 Dec; 27(6):633-8. PubMed ID: 11740686
[TBL] [Abstract][Full Text] [Related]
42. Hemostatic study before onset of disseminated intravascular coagulation.
Wada H; Minamikawa K; Wakita Y; Nakase T; Kaneko T; Ohiwa M; Tamaki S; Deguchi A; Mori Y; Deguchi K
Am J Hematol; 1993 Jul; 43(3):190-4. PubMed ID: 8352234
[TBL] [Abstract][Full Text] [Related]
43. [Studies on coagulation-fibrinolytic system in diabetic nephropathy--with reference to plasma TAT and alpha 2PIC].
Watanabe S; Ogihara T; Iyori S; Kaneshige H; Nomoto Y; Sakai H
Nihon Jinzo Gakkai Shi; 1990 Sep; 32(9):995-9. PubMed ID: 2148199
[TBL] [Abstract][Full Text] [Related]
44. Studies of blood coagulation-fibrinolysis regarding kallikrein-kinin system in severe preeclampsia.
Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
Agents Actions Suppl; 1992; 38 ( Pt 2)():342-9. PubMed ID: 1462840
[TBL] [Abstract][Full Text] [Related]
45. [Analysis of the fibrinolytic response on disseminated intravascular coagulation].
García Frade LJ; García Avello A
Sangre (Barc); 1993 Jun; 38(3):221-4. PubMed ID: 7692611
[No Abstract] [Full Text] [Related]
46. Management of disseminated intravascular coagulation associated with aortic aneurysm and vascular malformations.
Yamada S; Asakura H
Int J Hematol; 2021 Jan; 113(1):15-23. PubMed ID: 33175341
[TBL] [Abstract][Full Text] [Related]
47. Heterogeneity in the incidence and clinical manifestations of disseminated intravascular coagulation: a study of 204 cases.
Okajima K; Sakamoto Y; Uchiba M
Am J Hematol; 2000 Nov; 65(3):215-22. PubMed ID: 11074538
[TBL] [Abstract][Full Text] [Related]
48. Role of endothelin in disseminated intravascular coagulation.
Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Matsuda T
Am J Hematol; 1992 Oct; 41(2):71-5. PubMed ID: 1415185
[TBL] [Abstract][Full Text] [Related]
49. Fibrinolysis and fibrinogenolysis in disseminated intravascular coagulation.
Takahashi H; Tatewaki W; Wada K; Niwano H; Shibata A
Thromb Haemost; 1990 Jun; 63(3):340-4. PubMed ID: 2402738
[TBL] [Abstract][Full Text] [Related]
50. Activity and antigen levels of thrombin-activatable fibrinolysis inhibitor in plasma of patients with disseminated intravascular coagulation.
Watanabe R; Wada H; Watanabe Y; Sakakura M; Nakasaki T; Mori Y; Nishikawa M; Gabazza EC; Nobori T; Shiku H
Thromb Res; 2001 Oct; 104(1):1-6. PubMed ID: 11583733
[TBL] [Abstract][Full Text] [Related]
51. Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Mie DIC Study Group.
Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Shiku H
Thromb Haemost; 1995 Sep; 74(3):848-52. PubMed ID: 8571309
[TBL] [Abstract][Full Text] [Related]
52. Significance of elevated thrombin-antithrombin III complex and plasmin-alpha 2-plasmin inhibitor complex in the acute stage of nontraumatic subarachnoid hemorrhage.
Itoyama Y; Fujioka S; Takaki S; Morioka M; Hide T; Ushio Y
Neurosurgery; 1994 Dec; 35(6):1055-60. PubMed ID: 7533897
[TBL] [Abstract][Full Text] [Related]
53. Significance of hemostatic molecular markers during disseminated intravascular coagulation in patients with liver cirrhosis treated by endoscopic embolization for esophageal varices.
Koyama T; Kakishita E; Nakai Y; Okamoto E
Am J Hematol; 1991 Oct; 38(2):90-4. PubMed ID: 1719808
[TBL] [Abstract][Full Text] [Related]
54. Coagulation patterns of disseminated intravascular coagulation in acute promyelocytic leukemia.
Higuchi T; Shimizu T; Mori H; Niikura H; Omine M
Hematol Oncol; 1997 Nov; 15(4):209-17. PubMed ID: 9722892
[TBL] [Abstract][Full Text] [Related]
55. Alterations in coagulation and fibrinolysis after surgery for aortic aneurysm.
Oba J; Shiiya N; Matsui Y; Goda T; Sakuma M; Yasuda K
Surg Today; 1995; 25(6):532-5. PubMed ID: 7579961
[TBL] [Abstract][Full Text] [Related]
56. [Intravascular coagulation in acute promyelocytic leukemia: analysis of coagulation and fibrinolysis parameters].
Chuecas F; Loredo E; Muñoz B; Alfaro J; Grebe G; Lira P
Rev Med Chil; 1991 Sep; 119(9):984-9. PubMed ID: 1845106
[TBL] [Abstract][Full Text] [Related]
57. [Activation of intravascular coagulation and fibrinolysis in cases of APL].
Asakura H; Saito M; Jokaji H; Uotani C; Kumabashiri I; Matsuda T
Rinsho Byori; 1989 Apr; Spec No 81():224-8. PubMed ID: 2526885
[No Abstract] [Full Text] [Related]
58. [Studies on the fragments of FDP in 3 patients with DIC associated with acute promyelocytic leukemia].
Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
Rinsho Byori; 1993 Jun; 41(6):719-25. PubMed ID: 8361040
[TBL] [Abstract][Full Text] [Related]
59. Increase in the D-dimer levels during treatment in patients with acute myelogenous leukemia.
Velasco F; Torres A; Rojas R; Alvarez MA; Gomez P; Castillo D
Haemostasis; 1992; 22(3):117-23. PubMed ID: 1427455
[TBL] [Abstract][Full Text] [Related]
60. Circadian variations of plasma levels of blood coagulation/fibrinolysis molecular markers in progressive systemic sclerosis (PSS).
Maeda M; Kachi H; Kitajima Y
J Dermatol Sci; 1996 Oct; 13(1):18-24. PubMed ID: 8902649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
